The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category Health
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SROI | 29.81 | N/A | N/A |
| Calamos Antetokounmpo Global Sus Eqs ETF | |||
| REVS | 26.24 | -0.01 | -0.05% |
| Columbia Research Enhanced Value ETF | |||
| TLH | 101.70 | -0.16 | -0.16% |
| iShares 10-20 Year Treasury Bond ETF | |||
| CZA | 109.48 | -0.45 | -0.41% |
| Invesco Zacks Mid-Cap ETF | |||
| ROM | 67.96 | -3.57 | -4.99% |
| ProShares Ultra Technology | |||
A.I.dvisor indicates that over the last year, HGHRX has been closely correlated with VHCIX. These tickers have moved in lockstep 96% of the time. This A.I.-generated data suggests there is a high statistical probability that if HGHRX jumps, then VHCIX could also see price increases.
| Ticker / NAME | Correlation To HGHRX | 1D Price Change % | ||
|---|---|---|---|---|
| HGHRX | 100% | -2.68% | ||
| VHCIX - HGHRX | 96% Closely correlated | -2.17% | ||
| FSPHX - HGHRX | 92% Closely correlated | -2.59% | ||
| THISX - HGHRX | 91% Closely correlated | -3.21% | ||
| PRHSX - HGHRX | 91% Closely correlated | -3.21% | ||
| SHSAX - HGHRX | 91% Closely correlated | -2.37% | ||
More | ||||